Literature DB >> 19859804

Analysis of breast cancer related gene expression using natural splines and the Cox proportional hazard model to identify prognostic associations.

Bas Kreike1, Guus Hart, Harry Bartelink, Marc J van de Vijver.   

Abstract

Many studies correlating gene expression data to clinical parameters assume a linear increase or decrease of the clinical parameter under investigation with the expression of a gene. We have studied genes encoding important breast cancer-related proteins using a model for survival-type data that is based on natural splines and the Cox proportional hazard model, thereby removing the linearity assumption. Expression data of 16 genes were studied in relation to metastasis-free probability in a cohort of 295 consecutive breast cancer patients treated at The Netherlands Cancer Institute. The independent predictive power for disease outcome of the 16 individual genes was tested in a multivariable model with known clinical and pathological risk factors. There is a linear relationship between increasing expression and a higher or lower hazard for distant metastasis for ESR1, ERBB4, VEGF, CCNE2, EZH2, and UPA; for ERBB2, ERBB3, CCND1, CCNE1, EED, CXCR4, CCR7, SDF1, and PAI1 there is no clear increase or decrease; and for EGFR there seems to be a non-linear relation. Multivariable analysis showed that the 70-gene prognosis profile outperforms all the other variables in the model (hazard-rate 5.4, 95% CI 2.5-11.7; P = 0.000018). EGFR-expression seems to have a non-linear relation with disease outcome, indicating that lower but also higher expression of EGFR are associated with worse outcome compared to intermediate expression levels; the other genes show no or a linear relation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19859804     DOI: 10.1007/s10549-009-0588-6

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  11 in total

1.  Immune regulation of cancer.

Authors:  Mary L Disis
Journal:  J Clin Oncol       Date:  2010-06-01       Impact factor: 44.544

2.  Distinct and redundant functions of cyclin E1 and cyclin E2 in development and cancer.

Authors:  C Elizabeth Caldon; Elizabeth A Musgrove
Journal:  Cell Div       Date:  2010-01-17       Impact factor: 5.130

3.  Functional characterization of the 19q12 amplicon in grade III breast cancers.

Authors:  Rachael Natrajan; Alan Mackay; Paul M Wilkerson; Maryou B Lambros; Daniel Wetterskog; Monica Arnedos; Kai-Keen Shiu; Felipe C Geyer; Anita Langerød; Bas Kreike; Fabien Reyal; Hugo M Horlings; Marc J van de Vijver; Jose Palacios; Britta Weigelt; Jorge S Reis-Filho
Journal:  Breast Cancer Res       Date:  2012-03-20       Impact factor: 6.466

4.  Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells.

Authors:  P M Das; A D Thor; S M Edgerton; S K Barry; D F Chen; F E Jones
Journal:  Oncogene       Date:  2010-07-05       Impact factor: 9.867

5.  The antitumorigenic function of EGFR in metastatic breast cancer is regulated by expression of Mig6.

Authors:  Michael K Wendt; Whitney K Williams; Pete E Pascuzzi; Nikolas G Balanis; Barbara J Schiemann; Cathleen R Carlin; William P Schiemann
Journal:  Neoplasia       Date:  2015-01       Impact factor: 5.715

6.  MicroRNA-16 modulates HuR regulation of cyclin E1 in breast cancer cells.

Authors:  Xun Guo; Melanie C Connick; Jennifer Vanderhoof; Mohammad-Ali Ishak; Rebecca S Hartley
Journal:  Int J Mol Sci       Date:  2015-03-30       Impact factor: 5.923

7.  High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers.

Authors:  Cecilia Ahlin; Claudia Lundgren; Elin Embretsén-Varro; Karin Jirström; Carl Blomqvist; M -L Fjällskog
Journal:  Breast Cancer Res Treat       Date:  2017-05-20       Impact factor: 4.872

8.  Chemokine (C-C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinoma.

Authors:  Sultan N Sonbul; Kylie L Gorringe; Mohammed A Aleskandarany; Abhik Mukherjee; Andrew R Green; Ian O Ellis; Emad A Rakha
Journal:  J Pathol Clin Res       Date:  2017-03-30

9.  Prognostic Values of CCNE1 Amplification and Overexpression in Cancer Patients: A Systematic Review and Meta-analysis.

Authors:  Haiyue Zhao; Junling Wang; Yong Zhang; Ming Yuan; Shuangxiang Yang; Lisong Li; Huilin Yang
Journal:  J Cancer       Date:  2018-06-14       Impact factor: 4.207

10.  Modeling the relationship between baseline lactate dehydrogenase and prognosis in patients with extensive-disease small cell lung cancer: a retrospective cohort study.

Authors:  Liang Zhou; Zhihui Xie; Zhenyi Shao; Wen Chen; Hua Xie; Xin Cui; Guoyou Qin; Naiqing Zhao
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.